He discusses the need for rapid, efficient development of vaccines for emerging infectious diseases, the 3-prong approach for staying ahead of the curve, and more.
He discusses his latest research on the effects of tesamorelin use on non-alcoholic fatty liver disease (NAFLD) in patients with HIV, how the increase in obesity among patients with HIV affects the risk for...
He discusses his latest research on the effects of tesamorelin use on non-alcoholic fatty liver disease (NAFLD) in patients with HIV, how the increase in obesity among patients with HIV affects the risk for...
He discusses the biomarkers in the pipeline for diagnosing infectious diseases, including tuberculosis and sepsis, and details which ones are most likely to make it to clinical practice.
She talks about what we have learned from the Zika outbreak in Rio de Janeiro in 2015 and what research is being done to protect against the virus in endemic areas, a topic she also spoke about at IDWeek...
He explains why ANAC publicly opposes 2 federally proposed policy changes that concern protections from discrimination in health care and shelter housing for LGBTQ individuals.
He explains why ANAC publicly opposes 2 federally proposed policy changes that concern protections from discrimination in health care and shelter housing for LGBTQ individuals.
In this podcast, Joseph Bocchini Jr, MD, discusses a new study on adolescent vaccination data published by the Centers for Disease Control and Prevention. Are adolescents receiving the adequate...
In this podcast, she discusses the challenges of zika virus, including diagnostic challenges and those that arise in pregnancy, as well as the hope for a vaccine in the near future.
